NewslettersEndothelial Cell NewsUncategorizedOmeros Announces Preliminary Results from Additional Critically Ill COVID-19 Patients Treated with NarsoplimabBy Justin.choi - May 31, 2021010Omeros Corporation announced preliminary results from the second cohort of critically ill COVID-19 patients treated with narsoplimab in Bergamo, Italy.[Omeros Corporation] 6445212 nan items 1 apa 0 default asc 1 162780 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Press Release